1 However, mechanisms of its
antiarthritic activities are still poorly understood.
2 n vivo TNF inhibition assays, was tested for
antiarthritic activity in the AA rat model of arthritis.
3 of aminopterin analogues were evaluated for
antiarthritic activity in the mouse type II collagen mod
4 llagen antibody production suggests that the
antiarthritic activity of the effective compounds result
5 IL-10 is an effective
antiarthritic agent and has a major effect on the presen
6 ther exploited for the selective delivery of
antiarthritic agents into the inflamed joints to enhance
7 d arthritis and has the capacity to generate
antiarthritic CD8+ Treg cells and expand the relative nu
8 e SSRIs may provide a template for potential
antiarthritic drug development.
9 nthesized, characterized, and along with the
antiarthritic drug, auranofin, tested as inhibitors of t
10 gation to utilize its potential effect as an
antiarthritic drug.
11 ble model for identifying remission-inducing
antiarthritic drugs and has predictive value with respec
12 Many of the conventional
antiarthritic drugs are effective in suppressing inflamm
13 scaffold for development of next-generation
antiarthritic drugs.
14 f IDO2; however, deleting Runx1 reversed the
antiarthritic effect of IDO2 loss in this model.
15 Interestingly, an
antiarthritic effect was also observed in opposing contr
16 rticular transgene expression with promising
antiarthritic effects in animal models.
17 so synergized with the steroid to elicit its
antiarthritic effects.
18 xidant, antimutagenic, anti-inflammatory and
antiarthritic effects.
19 efore, we undertook studies to determine the
antiarthritic efficacy and mechanism of action of a well
20 Scientific evidence is lacking for the
antiarthritic efficacy of turmeric dietary supplements t
21 Here, we assess the
antiarthritic efficiency of glutaminyl cyclase (QC) inhi
22 In this study we queried whether
antiarthritic functions for this effector of endogenous
23 e represent a novel class of small molecular
antiarthritic inhibitors.
24 angiogenesis and suggest that an additional
antiarthritic mechanism afforded by IL-1 inhibitors, but
25 d individually and in combination, for their
antiarthritic potency in the mouse CIA model.
26 The aim of this study was to assess the
antiarthritic potential of 2 SSRIs, fluoxetine and cital
27 These data highlight the
antiarthritic potential of the SSRI drug family and prov
28 eptides activate specific receptors to exert
antiarthritic properties, avoiding excessing inflammatio
29 logy to deliver genes whose products possess
antiarthritic properties; the current emphasis is on tra
30 rch while improving the development of novel
antiarthritic therapeutics.